iShares Nasdaq Biotechnology ETF (IBB)

Add to Watchlists
Create an Alert
104.19 +2.27  +2.23% NASDAQ Nov 15, 17:00 Delayed 2m USD
View Full Chart
IBB Price Chart

IBB Performance

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -8.39% -8.40% -4.16% 85
3M -13.02% -13.04% -6.68% 82
6M -5.19% -5.24% 0.22% 82
YTD -4.38% -4.36% 5.94% 85
1Y 0.52% 0.50% 10.52% 88
3Y -1.65% -1.65% 7.09% 92
5Y 8.05% 8.05% 11.22% 78
10Y 16.37% 16.40% 16.18% 38
15Y 10.77% 10.76% 10.91% 53
20Y -- -- 10.72% --
As of Nov. 14, 2018. Returns for periods of 1 year and above are annualized.

IBB Asset Allocation

Type % Net % Long % Short
Cash 0.05% 0.05% 0.00%
Stock 99.95% 99.95% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Nov. 14, 2018

IBB Region Exposure

Americas 97.85%
North America 97.85%
Latin America 0.00%
Greater Europe 1.77%
United Kingdom 0.59%
Europe Developed 1.18%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.38%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.38%
Market Classification
% Developed Markets 99.62%
% Emerging Markets 0.38%
As of Nov. 13, 2018. Region breakdown data is calculated by using the long position holdings of the portfolio.

IBB Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.06%
Energy 0.00%
Financial Services 0.00%
Healthcare 99.92%
Industrials 0.00%
Real Estate 0.00%
Technology 0.02%
Utilities 0.00%
As of Nov. 14, 2018

IBB Stock Market Capitalization

Giant 18.00%
Large 35.79%
Medium 26.85%
Small 16.00%
Micro 3.36%
As of Nov. 14, 2018

IBB Stock Style Exposure

Large Cap Value 20.96%
Large Cap Blend 8.90%
Large Cap Growth 26.65%
Mid Cap Value 3.11%
Mid Cap Blend 3.18%
Mid Cap Growth 19.98%
Small Cap Value 0.70%
Small Cap Blend 4.02%
Small Cap Growth 12.48%
As of Nov. 14, 2018
View More Holdings

IBB Top 10 Holdings

Symbol Name % Weight Price % Chg
AMGN Amgen Inc 9.09% 192.45 +1.10%
GILD Gilead Sciences Inc 8.89% 69.78 -1.09%
BIIB Biogen Inc 8.47% 321.72 +2.61%
CELG Celgene Corp 6.74% 69.98 +0.50%
ILMN Illumina Inc 6.24% 319.51 +3.66%
VRTX Vertex Pharmaceuticals Inc 4.26% 166.67 +1.27%
REGN Regeneron Pharmaceuticals Inc 3.96% 341.65 +1.29%
ALXN Alexion Pharmaceuticals Inc 3.73% 119.68 +3.07%
MYL Mylan NV 2.54% 35.14 +2.66%
BMRN Biomarin Pharmaceutical Inc 2.35% 94.75 +3.26%
As of Nov. 14, 2018
Advertisement

IBB One Page Reports

IBB Basic Info

Style
Equity Style Large Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Technology
Fund Owner Firm Name iShares
Benchmark Index
NASDAQ Biotechnology TR USD
100.0%

IBB Manager Info

Name Tenure
Alan Mason 2.55 yrs
Amy Whitelaw 0.25 yrs
Diane Hsiung 10.84 yrs
Greg Savage 10.84 yrs
Jennifer Hsui 6.25 yrs
Rachel Aguirre 0.25 yrs

IBB Net Fund Flows

1M -202.67M
3M -411.46M
6M -418.70M
YTD -1.583B
1Y -1.426B
3Y 134.23M
5Y 2.218B
10Y 2.406B
As of Oct. 31, 2018

IBB Risk Info

Beta (5Y) 1.362
Max Drawdown (All) 62.85%
Historical Sharpe (10Y) 0.8847
Historical Sortino (All) 0.5462
30-Day Rolling Volatility 32.50%
Daily Value at Risk (VaR) 1% (All) 4.84%
Monthly Value at Risk (VaR) 1% (All) 19.32%

IBB Fundamentals

Dividend Yield TTM (11-15-18) 0.30%
30-Day SEC Yield (4-30-18) 0.13%
7-Day SEC Yield --
Weighted Average PE Ratio 27.24
Weighted Average Price to Sales Ratio 5.486
Weighted Average Price to Book Ratio 4.654
Weighted Median ROE 4.51%
Weighted Median ROA -2.57%
Forecasted Dividend Yield 0.65%
Forecasted PE Ratio 14.29
Forecasted Price to Sales Ratio 4.709
Forecasted Price to Book Ratio 3.439
Number of Holdings 193
As of Nov. 14, 2018

IBB Growth Estimates

Forecasted 5 Yr Earnings Growth 14.55%
Forecasted Book Value Growth 13.73%
Forecasted Cash Flow Growth 2.77%
Forecasted Earnings Growth -12.41%
Forecasted Revenue Growth 11.45%
As of Nov. 14, 2018

IBB Comparables

Edit

IBB Attributes

Key Dates
Inception Date 2/5/2001
Termination Date
Last Annual Report Date 3/31/2018
Last Prospectus Date 8/1/2018
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

IBB Excel Add-In Codes

  • Name: =YCI("IBB","name")
  • Broad Asset Class: =YCI("IBB", "broad_asset_class")
  • Broad Category: =YCI("IBB", "broad_category_group")
  • Prospectus Objective: =YCI("IBB", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.